Tissue Regenix Group plc (TRX.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 53M |
| Enterprise Value | 61.6M |
| P/E Ratio | -9.61 |
| PEG Ratio | -0.26 |
| Price/Sales Ratio | 0.24 |
| Price/Book Ratio | 0.23 |
| Enterprise/Revenue | 0.54 |
| Enterprise/EBITDA | 11.37 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | -0.02 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 28.65M |
| Revenue/Share | 0.41 |
| Gross Profit | 13.62M |
| EBITDA | 1.36M |
| Net Income | -713,000 |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 1.08M |
| Total Cash/Share | 0.03 |
| Total Debt | 11M |
| Total Debt/Equity | 0.35 |
| Current Ratio | 3.46 |
| Book Value Per Share | 0.41 |
Price History
| 52-Week Change | -87.39 |
| 52-Week High | 66 |
| 52-Week Low | 4.77 |
| Moving Average 50 Days | 21.12 |
| Moving Average 200 Days | 34.25 |
Statistics
| Average Volume | 394,900 |
| Shares Outstanding | 71.23M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | April 28, 2023 |
AD
